NeuroMetrix (NURO) Revenue & Revenue Breakdown
NeuroMetrix Revenue Highlights
Latest Revenue (Y)
$5.90M
Latest Revenue (Q)
$769.15K
NeuroMetrix Revenue by Period
NeuroMetrix Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.90M | -28.52% |
| 2022-12-31 | $8.26M | 0.03% |
| 2021-12-31 | $8.25M | 11.87% |
| 2020-12-31 | $7.38M | -20.43% |
| 2019-12-31 | $9.27M | -42.37% |
| 2018-12-31 | $16.09M | -5.86% |
| 2017-12-31 | $17.09M | 42.11% |
| 2016-12-31 | $12.03M | 64.76% |
| 2015-12-31 | $7.30M | 32.42% |
| 2014-12-31 | $5.51M | 4.43% |
| 2013-12-31 | $5.28M | -30.32% |
| 2012-12-31 | $7.58M | -27.14% |
| 2011-12-31 | $10.40M | -25.20% |
| 2010-12-31 | $13.90M | -46.82% |
| 2009-12-31 | $26.14M | -16.01% |
| 2008-12-31 | $31.12M | -30.26% |
| 2007-12-31 | $44.62M | -19.24% |
| 2006-12-31 | $55.25M | 61.09% |
| 2005-12-31 | $34.30M | 91.39% |
| 2004-12-31 | $17.92M | 95.47% |
| 2003-12-31 | $9.17M | 116.98% |
| 2002-12-31 | $4.23M | 21.96% |
| 2001-12-31 | $3.46M | - |
NeuroMetrix generated $5.90M in revenue during NA 2023, up -28.52% compared to the previous quarter, and up 36.68% compared to the same period a year ago.
NeuroMetrix Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $769.15K | -29.67% |
| 2024-03-31 | $1.09M | -17.01% |
| 2023-12-31 | $1.32M | 9.52% |
| 2023-09-30 | $1.20M | -27.33% |
| 2023-06-30 | $1.66M | -4.00% |
| 2023-03-31 | $1.72M | -6.64% |
| 2022-12-31 | $1.85M | -6.13% |
| 2022-09-30 | $1.97M | -7.96% |
| 2022-06-30 | $2.14M | -7.13% |
| 2022-03-31 | $2.30M | 26.49% |
| 2021-12-31 | $1.82M | -11.83% |
| 2021-09-30 | $2.06M | -6.74% |
| 2021-06-30 | $2.21M | 2.69% |
| 2021-03-31 | $2.16M | 19.10% |
| 2020-12-31 | $1.81M | -11.12% |
| 2020-09-30 | $2.04M | 49.72% |
| 2020-06-30 | $1.36M | -37.39% |
| 2020-03-31 | $2.17M | 27.25% |
| 2019-12-31 | $1.71M | -18.25% |
| 2019-09-30 | $2.09M | -11.33% |
| 2019-06-30 | $2.35M | -24.60% |
| 2019-03-31 | $3.12M | -16.25% |
| 2018-12-31 | $3.73M | 1.69% |
| 2018-09-30 | $3.67M | -2.26% |
| 2018-06-30 | $3.75M | -24.10% |
| 2018-03-31 | $4.94M | 0.27% |
| 2017-12-31 | $4.93M | 38.99% |
| 2017-09-30 | $3.55M | -17.71% |
| 2017-06-30 | $4.31M | 0.09% |
| 2017-03-31 | $4.31M | 15.90% |
| 2016-12-31 | $3.72M | 9.62% |
| 2016-09-30 | $3.39M | 28.03% |
| 2016-06-30 | $2.65M | 16.36% |
| 2016-03-31 | $2.28M | -16.88% |
| 2015-12-31 | $2.74M | 33.25% |
| 2015-09-30 | $2.05M | 67.71% |
| 2015-06-30 | $1.22M | -4.52% |
| 2015-03-31 | $1.28M | -8.99% |
| 2014-12-31 | $1.41M | -1.27% |
| 2014-09-30 | $1.43M | 6.26% |
| 2014-06-30 | $1.34M | 0.92% |
| 2014-03-31 | $1.33M | -5.04% |
| 2013-12-31 | $1.40M | 6.65% |
| 2013-09-30 | $1.31M | 13.29% |
| 2013-06-30 | $1.16M | -17.20% |
| 2013-03-31 | $1.40M | -7.99% |
| 2012-12-31 | $1.52M | -13.69% |
| 2012-09-30 | $1.76M | -20.00% |
| 2012-06-30 | $2.21M | 5.97% |
| 2012-03-31 | $2.08M | -11.79% |
| 2011-12-31 | $2.36M | -7.83% |
| 2011-09-30 | $2.56M | -0.45% |
| 2011-06-30 | $2.57M | -11.46% |
| 2011-03-31 | $2.90M | -5.27% |
| 2010-12-31 | $3.07M | -10.19% |
| 2010-09-30 | $3.41M | -11.37% |
| 2010-06-30 | $3.85M | 3.76% |
| 2010-03-31 | $3.71M | -40.36% |
| 2009-12-31 | $6.23M | -1.59% |
| 2009-09-30 | $6.33M | -6.43% |
| 2009-06-30 | $6.76M | -0.95% |
| 2009-03-31 | $6.83M | 9.22% |
| 2008-12-31 | $6.25M | -14.17% |
| 2008-09-30 | $7.28M | -14.28% |
| 2008-06-30 | $8.49M | -6.65% |
| 2008-03-31 | $9.10M | -9.91% |
| 2007-12-31 | $10.10M | - |
NeuroMetrix generated $769.15K in revenue during Q2 2024, up -29.67% compared to the previous quarter, and up 44.59% compared to the same period a year ago.
NeuroMetrix Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HSCS | Heart Test Laboratories | $18.60M | - |
| VVOS | Vivos Therapeutics | $13.80M | $4.05M |
| NUWE | Nuwellis | $8.86M | $2.19M |
| RSLS | ReShape Lifesciences | $8.68M | $1.97M |
| NURO | NeuroMetrix | $5.90M | $769.15K |
| OPGN | OpGen | $3.42M | $28.00K |
| SINT | Sintx | $2.63M | $687.00K |
| NAOV | NanoVibronix | $2.28M | $817.00K |
| TIVC | Tivic Health Systems | $1.18M | $140.00K |
| IINN | Inspira Technologies Oxy B.H.N. | - | - |
| BJDX | Bluejay Diagnostics | - | - |
| BBLG | Bone Biologics | - | - |
NURO Revenue FAQ
What is NeuroMetrix’s yearly revenue?
NeuroMetrix's yearly revenue for 2023 was $5.9M, representing a decrease of -28.52% compared to 2022. The company's yearly revenue for 2022 was $8.26M, representing an increase of 0.03% compared to 2021. NURO's yearly revenue for 2021 was $8.25M, representing an increase of 11.87% compared to 2020.
What is NeuroMetrix’s quarterly revenue?
NeuroMetrix's quarterly revenue for Q2 2024 was $769.15K, a -29.67% decrease from the previous quarter (Q1 2024), and a -53.55% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.09M, a -17.01% decrease from the previous quarter (Q4 2023), and a -36.60% decrease year-over-year (Q1 2023). NURO's quarterly revenue for Q4 2023 was $1.32M, a 9.52% increase from the previous quarter (Q3 2023), and a -28.67% decrease year-over-year (Q4 2022).
What is NeuroMetrix’s revenue growth rate?
NeuroMetrix's revenue growth rate for the last 3 years (2021-2023) was -28.50%, and for the last 5 years (2019-2023) was -36.36%.